Epizyme to Present at Upcoming Investor Conferences
Feb 02, 2017 11:30 am UTC| Business
CAMBRIDGE, Mass., Feb. 02, 2017 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that the Company will present at the following investor...
COLFAX REPORTS FOURTH QUARTER 2016 RESULTS
Feb 02, 2017 11:01 am UTC| Business
Annapolis Junction, MD, Feb. 02, 2017 -- Exceeded full year 2016 guidance with fourth quarter net income per dilutive share of $0.31 and adjusted net income per share of $0.46 Drove structural cost changes to...
Sensata Technologies Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 02, 2017 11:00 am UTC| Business
HENGELO, the Netherlands, Feb. 02, 2017 -- Sensata Technologies (NYSE:ST) today announced financial results for its fourth quarter and full year ended December31, 2016. Revenue was $788.4 million in the fourth quarter...
Feb 02, 2017 11:00 am UTC| Business
IRVINE, Calif., Feb. 02, 2017 -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announces that James W....
The Breast Cancer Research Foundation to Ring The Nasdaq Stock Market Opening Bell
Feb 02, 2017 11:00 am UTC| Business
ADVISORY, Feb. 02, 2017 -- What:The Breast Cancer Research Foundation will visit the Nasdaq MarketSite in Times Square to raise cancer awareness ahead of World Cancer Day on February 4. In honor of the occasion,...
Feb 02, 2017 11:00 am UTC| Business
LIVONIA, Mich., Feb. 02, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia and NAFLD/NASH,...
Smart Sand, Inc. Prices Public Offering
Feb 02, 2017 11:00 am UTC| Business
THE WOODLANDS, Texas, Feb. 02, 2017 -- Smart Sand, Inc. (the “Company”) has priced a public offering of 5,950,000 shares of its common stock at $17.50 per share, of which 1,500,000 shares are to be sold by the Company...